Pharma and Healthcare Segments

AI Visibility for Pharma and Healthcare Segments

Buyers across the pharmaceutical and healthcare supply chain are starting their research with AI assistants, not just search engines. Whether a procurement team is sourcing an API, qualifying a CDMO or comparing excipient suppliers, the first impression often comes from an AI-generated answer.

AEO Dose works with manufacturers, formulators and suppliers across pharma and healthcare to find out whether their business shows up in those answers, and what to do if it does not.

Tailored to your segment's buyer questions
Pharmaceutical manufacturing cleanroom with workers in protective suits at processing equipment
Industry Segments

From API Manufacturers to CDMOs, Excipient and Sterile-Product Makers

We tailor AI visibility checks and audits to the realities of each segment. Every industry has different buyer questions, different technical claims to verify and different competitors to benchmark against.

Segment 01

API and Pharmaceutical Ingredient Manufacturers

Visibility for specifications, regulatory filings and manufacturing capability questions across AI platforms.

Segment 02

Formulation Manufacturers

How clearly AI systems describe your formulation expertise and product categories to evaluating buyers.

Segment 03

CMOs and CDMOs

Whether AI answers surface your capabilities when buyers ask who can manufacture or develop a specific product.

Segment 04

Excipient Suppliers

Presence in questions about functional categories, grades and compliance documentation from procurement teams.

Segment 05

Injectable and Sterile-Product Manufacturers

Visibility around aseptic processing, fill-finish and sterile manufacturing capability questions.

Segment 06

Nutraceutical Businesses

How AI assistants represent your formulations, certifications and manufacturing capacity to health-sector buyers.

Segment 07

Oral Care Manufacturers

Discoverability for private label, contract manufacturing and formulation questions in an increasingly competitive space.

Segment 08

Pharmaceutical Raw-Material Suppliers

Clarity and citation quality when AI systems answer sourcing and supplier-comparison questions for procurement.

Why It Matters

Why AI Discovery Matters for Pharma Procurement Decisions

Pharma and healthcare procurement often starts long before a request for quotation is sent. Buyers use AI assistants to shortlist potential suppliers, understand manufacturing capabilities, compare regulatory credentials and narrow down a list before they ever visit a website directly.

If your business is missing from those early answers, or mentioned without a link or without the detail a buyer needs, you may be filtered out before a conversation ever starts.

This matters more in regulated industries, where buyers also look for evidence of compliance, documentation and credibility, not just a product listing.

Pharma procurement journeyAI touchpoints
01
Discovery
Buyer asks AI to recommend suppliers
ChatGPT, Gemini or Perplexity generate a shortlist from AI-synthesized knowledge
High impact
02
Evaluation
Capabilities and credentials compared
AI answers summarize regulatory standing, manufacturing scale and compliance evidence
Critical
03
Shortlisting
Website visit (or not)
Buyers with a clear AI-given impression may visit your site or skip it entirely
Decisive
04
Contact
RFQ or inquiry sent
Only suppliers who cleared the AI-assisted filter reach this stage
Goal
Our Approach

Tailoring Question Sets to Your Segment's Buyer Journey

A generic set of AI questions will not reveal what matters to your buyers. AEO Dose builds question sets around the way your specific segment actually searches and evaluates, organized across the stages buyers move through.

Question framework by buyer stage5 stages
01
DiscoverySupplier identification questions
Which CDMOs in Europe specialise in solid dose forms?
Who manufactures GMP-grade Ibuprofen API at scale?
02
EvaluationCapability and credential questions
What regulatory filings does this manufacturer hold?
Does this excipient supplier offer USP and EP grades?
03
Product and CapabilityTechnical specificity questions
What fill-finish technologies does this CDMO offer?
Which certifications does this nutraceutical manufacturer hold?
04
CommercialPricing and terms questions
What are typical MOQs for CDMO development projects?
05
Support and Follow-upPost-selection questions
How does this manufacturer handle regulatory audit support?
Segment Examples

The goal is the same across segments: find the gaps and fix what matters first.

For an API manufacturer, that might mean testing questions about regulatory filings and manufacturing scale. For a CDMO, it might mean testing questions about development stage capabilities and technology platforms. For an excipient supplier, it might mean testing questions about functional grades and documentation support.

API Manufacturer
Regulatory and manufacturing scale testing
Questions test whether AI answers correctly describe your filing status, manufacturing capacity and approved markets.
CDMO
Development capability and technology platform testing
Questions test whether AI surfaces your development stage offerings, technology platforms and capacity when buyers search for partners.
Excipient Supplier
Functional grade and documentation testing
Questions test whether AI answers correctly describe your available grades, compendial compliance and documentation support.
Nutraceutical Brand
Certification and capacity testing
Questions test how AI assistants represent your formulations, third-party certifications and contract manufacturing capacity.
Questions

Common Questions About Industry-Specific AI Audits

What pharma and healthcare businesses typically ask before starting their AI visibility audit.

Which pharma and healthcare segments does AEO Dose serve?
AEO Dose works with API and pharmaceutical ingredient manufacturers, formulation manufacturers, CMOs and CDMOs, excipient suppliers, injectable and sterile-product manufacturers, nutraceutical businesses, oral care manufacturers and pharmaceutical raw-material suppliers. If your business is not listed here but you believe your buyers are using AI to research suppliers in your category, contact us to discuss whether an audit would be relevant.
Why does AI visibility matter specifically for pharma procurement?
Pharma and healthcare procurement often starts before a request for quotation is sent. Buyers use AI assistants to shortlist suppliers, compare manufacturing capabilities and narrow down options. If your business is missing from those early answers, or mentioned without the detail a buyer needs, you may be filtered out before a conversation ever starts. In regulated industries, buyers also look for evidence of compliance and credibility, not just a product listing.
How does AEO Dose tailor question sets for each segment?
AEO Dose builds question sets around the way each specific segment actually searches and evaluates, organized across discovery, evaluation, product and capability, commercial, and support stages. For an API manufacturer, that might mean testing questions about regulatory filings and manufacturing scale. For a CDMO, questions about development stage capabilities and technology platforms. For an excipient supplier, questions about functional grades and documentation support.
Do you benchmark against our actual competitors?
Yes, in the full AEO Readiness Audit. Competitive benchmarking compares your brand presence, citation quality, sentiment, share of voice and content freshness against the suppliers and manufacturers that appear in the same AI answers as you. This gives you a realistic view of where you stand relative to the businesses you actually compete with, not a generic benchmark.
My segment is highly technical. Can you handle the terminology?
Yes. Our audits are built on pharmaceutical industry knowledge, including familiarity with regulated-environment documentation and validation practices, combined with a digital visibility methodology. Question sets are written in the language your buyers actually use, and findings are specific to your technical context.
Where do I start if I am not sure which audit is right for my segment?
Start with the free AI Visibility Check. It gives you a concrete baseline across two AI platforms and ten buyer questions relevant to your segment, with an initial view of website readiness gaps. That baseline makes it easy to decide whether a full audit with competitive benchmarking and a prioritized action plan is the right next step.
Get Started

See How AEO Dose Fits Your Industry Segment

Every pharma and healthcare segment has its own buyer questions and its own competitive landscape in AI answers. Start with a free baseline check built around questions relevant to your segment, or talk to us about a full audit with competitive benchmarking against the suppliers and manufacturers you actually compete with.

No payment required for the free check. We will respond within one to two business days.

Segment-specific question sets Pharma industry expertise Real buyer questions, not keywords Findings within 1 to 2 business days

Ready to check your AI visibility?

Contact us to request your free AI Visibility Check or to discuss a full AEO Readiness Audit tailored to your pharma or healthcare segment.

No payment required for the free check.